Over the past fifteen years, the treatment of many types of cancer has been transformed by the development of innovative therapies such as immunotherapy, cell therapy, or targeted therapy. The understanding of tumor processes has also advanced dramatically. cancers are now increasingly classified by their genetic characteristics rather than by organ. Originally reserved for metastatic pathologies, these innovations are now targeting less advanced stages of cancer, and therefore a larger number of patients. The cost of these treatments is placing a growing burden on the health care system and causing concern among physicians. The National Academy of Medicine just released a report “Problems caused by new molecules in oncology”which points out system limits and suggests ways of improvement, production evaluation tools.
One of the merits of this report is the insight…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.